Provectus Biopharmaceuticals Inc. Appoints Christopher Kaplan To Its Strategic Advisory Board
Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that it has appointed Christopher Kaplan to its Strategic Advisory Board effective immediately.
Help employers find you! Check out all the jobs and post your resume.